Analysts surveyed by FactSet anticipate earnings of 12 cents per share, a decline from the 14 cents reported during the same period last year. Revenue is expected to settle at $10.85 billion, sliding from the $11.1 billion benchmark set a year ago. The results arrive as the company navigates a complex turnaround plan, with management previously signaling that recovery in key segments—specifically China and the Converse brand—remains slower than initially projected.
In section Market Quotes
Nike Faces Sluggish Quarter Amid Leadership Transition and Marketing Hurdles
As Nike prepares to report fiscal fourth-quarter results this Tuesday, the athletic giant faces a projected dip in both earnings and revenue. With shares down 20% over the last three months, investors are bracing for a period of transition marked by shifting executive leadership and questions surrounding the effectiveness of recent global marketing campaigns.

Attention remains fixed on the transition in the C-suite. David Denton, current CFO at Pfizer, is slated to succeed Matthew Friend on August 17. Market observers at Jefferies suggest the company may issue conservative guidance to grant Denton the flexibility to establish his own long-term financial targets during the upcoming Investor Day. Meanwhile, the effectiveness of Nike’s World Cup strategy has come under scrutiny. KeyBanc Capital Markets analysts noted that a crowded field of competitors launching identical pink footwear may have diluted Nike’s brand impact, potentially limiting the anticipated sales boost from the tournament.
Comments (0)
No comments yet. Be the first!